CCX Pharma
3 known investors
CCX offers a platform for managing access agreement activities, with a focus on collaboration between payers and pharmaceutical companies. It serves the healthcare and pharmaceutical market.
Also known as CCX · CCX Pharma
Investors · 3
Company profile
researched Aug 2026CCX Pharma, operating as CCX, develops digital software for market access and pricing in the life sciences sector. For pharmaceutical companies, the platform is positioned as a single enterprise system intended to replace fragmented legacy tools, consolidating contract planning, pricing modelling and intelligence from global and affiliate teams in one place. For payers and health systems, CCX supplies technical infrastructure used to set up and administer innovative contracts, reduce administrative workload around deals, and support arrangements such as indication-based pricing and confidential rebates.
The product is organised into three tools. CCX Planning is used to plan, model and analyse contract scenarios and to collaborate on and communicate proposed solutions. Deal Admin supports contract administration, coordination between pharma and payer counterparties, and associated learning and data sharing. CCX Digital Negotiation, offered on an invite-only basis, is aimed at compressing deal execution timelines from months to hours. The company describes its offering as covering the full sequence of planning, negotiating and administering access agreements on configurable infrastructure.
Founding story
The company was founded in 2017 by Nathan Sigworth.
Business model
CCX licenses an enterprise software platform to pharmaceutical companies and to payers and health systems, with prospective customers directed to request a demonstration; access to the Digital Negotiation tool is invite-only.
Latest developments
Hoxton Ventures added CCX Pharma to its portfolio in 2023 via the Hoxton III fund. The company markets three products: CCX Planning, Deal Admin and the invite-only CCX Digital Negotiation.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positions itself as an enterprise platform for market access and pricing serving both pharmaceutical companies and payers; it is a venture-backed company in the Hoxton Ventures portfolio.
Covers planning, negotiation and administration of access agreements in one configurable system rather than separate legacy tools, provides real-time visibility across global and affiliate teams, and offers a digital negotiation capability intended to shorten deal cycles from months to hours.
Technology
A cloud-delivered platform combining contract scenario planning and pricing modelling, collaboration and communication features, secure technical infrastructure for payer-side contract administration and data sharing, and a digital negotiation module supporting mechanisms such as indication-based pricing and confidential rebates.
Go-to-market
Direct enterprise sales to pharma and payer organisations via demo requests on the company website, with the digital negotiation product distributed on an invitation-only basis.
Global pharmaceutical and life sciences organisations, including global and affiliate market access and pricing teams, plus payers and health systems involved in contracting and rebate arrangements.
Geography
Headquartered in Zug, Switzerland, serving global pharmaceutical companies and payers.
History
CCX Pharma was founded in 2017 by Nathan Sigworth and is based in Zug, Switzerland. Hoxton Ventures invested in the company in 2023 through its Hoxton III fund.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 1
launches, deals, and filingsHoxton Ventures lists CCX Pharma as a portfolio investment made in 2023 out of its Hoxton III fund; no amount disclosed.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- CCX Pharmaccx.tech · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does CCX Pharma do?
- CCX Pharma builds enterprise software for pharmaceutical market access, pricing and payer contracting.
- Who are CCX Pharma's investors?
- CCX Pharma's investors include Acurio Ventures, Hoxton Ventures, LifeX Ventures.